Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Puma Biotechnology, Inc.
< Previous
1
2
3
Next >
Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results
July 21, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 06, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
June 06, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT ‘Basket’ Trial of Neratinib at the ASCO 2022 Annual Meeting
June 04, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2022 ASCO Annual Meeting
May 26, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 11, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports First Quarter 2022 Financial Results
May 05, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Announces Publication of Neratinib Abstract Titles for the 2022 ASCO Annual Meeting
April 27, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results
April 21, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 05, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results
February 16, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology’s NERLYNX® Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer
January 12, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Releases Updated Corporate Presentation
January 10, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology to Present at the H.C. Wainwright BioConnect Conference
January 04, 2022
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Presents Updates from the SUMMIT Trial at the 2021 SABCS Annual Meeting
December 10, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Announces U.S Patent Term Extension for NERLYNX® (neratinib)
November 23, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual Meeting
November 20, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology to Present Neratinib Data at the San Antonio Breast Cancer Symposium (SABCS)
November 19, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Third Quarter 2021 Financial Results
November 04, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
October 21, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
October 06, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology to Present at the Cantor Virtual Global Healthcare Conference
September 21, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 07, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
August 06, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
Puma Biotechnology Reports Second Quarter 2021 Financial Results
August 05, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Tickers
PBYI
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.